Quick Answer
Grace Therapeutics, Inc. reported Total Assets of $71.99 million for fiscal year 2025.
Grace Therapeutics, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $71.99M | -1.8% |
| 2024 | $73.30M | -7.4% |
| 2023 | $79.12M | -38.5% |
| 2022 | $128.62M | +105.9% |
| 2021 | $62.46M | +173.3% |
| 2020 | $22.85M | -38.1% |
| 2019 | $36.90M | +60.7% |
| 2018 | $22.96M | -9.8% |
| 2017 | $25.46M | -3.5% |
| 2017 | $26.37M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $68.49M | +11.9% | +2.9% |
| September 30, 2025 | $66.58M | +1.9% | -4.6% |
| June 30, 2025 | $69.81M | +0.1% | -3.0% |
| March 31, 2025 | $71.99M | -1.8% | +17.6% |
| December 31, 2024 | $61.22M | -19.6% | -6.3% |
| September 30, 2024 | $65.35M | -16.4% | -6.3% |
| June 30, 2024 | $69.72M | -4.5% | -4.9% |
| March 31, 2024 | $73.30M | -7.4% | -3.8% |
- Grace Therapeutics, Inc. showed a decrease of -1.8% in Total Assets compared to the prior fiscal year.
- Over the 2017–2025 period, Grace Therapeutics, Inc.’s total assets has grown by 173.0% (from $26.37 million to $71.99 million).
- The most recent figure is from Grace Therapeutics, Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on June 23, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: